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OBJECTIVE — Toevaluatethepsychologicalburdenofparentsfacingincreasingriskoftype
1 diabetes in their children.
RESEARCH DESIGN AND METHODS — In the population-based Type 1 Diabetes
Prediction and Prevention (DIPP) Study, newborn infants with HLA-DQB1–conferred diabetes
risk were enrolled in sequential analyses of diabetes-associated autoantibodies. Those persis-
tently positive for at least two autoantibodies were recruited to a randomized double-blinded
intervention trial. The experience of stress in parents of 664 children was measured using
Parenting Stress Index self-report inventory.
RESULTS — While diagnosis of diabetes increased parental stress, the appearance of autoan-
tibodies or participation in the intervention trial did not. Mothers had higher stress levels than
fathers. Single parenthood and chronically ill family members increased parental stress.
CONCLUSIONS — Parental stress was not increased by notiﬁcation of autoantibody posi-
tivityorbyparticipationinaninterventiontrial.Otherdemandingfamilyconditionscontributed
to the experience of stress.
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N
atural history and prevention stud-
ies screening genetic risk for type 1
diabeteshaveraisedconcernsofthe
burden of risk awareness in asymptom-
atic individuals, most of whom will never
develop the disease (1,2).
RESEARCH DESIGN AND
METHODS
Study subjects
The population-based Type 1 Diabetes
Prediction and Prevention (DIPP) Study
screened neonates for HLA-DQB1–
conferred diabetes risk, enrolling chil-
dren at risk in sequential monitoring for
diabetes-associated autoantibodies. Chil-
dren permanently positive for multiple
autoantibodies were invited to a random-
ized double-blinded prevention trial
comparing intranasal insulin with pla-
cebo (3).
Parentsof1,125participantsreceived
a self-administered questionnaire (see be-
low). There were 1,204 questionnaires
(59%) returned by parents of 664 chil-
dren. A total of 457 children showed ge-
netic predisposition only, whereas 188
had diabetes-associated autoantibodies
and 19 had progressed to diabetes. The
time from notiﬁcation of autoantibody
positivity ranged from 0.5 to 6.7 years
(mean 2.9).
A total of 35 parents had a child diag-
nosed with diabetes, and 326 had a child
with diabetes-associated autoantibodies
only. There were 18 parents of a child
with diabetes (51.4%) and 84 parents of
an autoantibody-positive child (25.8%)
whoenrolledtheirchildintheprevention
trial. There were 69 parents who had a
child eligible for the trial but had chosen
nottoparticipate,whereasthechildrenof
173 parents had tested only transiently
positive for one autoantibody species. A
total of 843 control parents, whose child
had not developed autoantibodies, were
matchedwiththeparentsofchildrenwith
diabetes(n197)orautoantibodies(n
646) for parental age, child’s age, and
study site. Age, employment, marital sta-
tus, place of living, and chronic illness in
the family were recorded.
Measurement of parenting stress
Eleven questions focusing on parenting
stress were selected from the 34-item
Swedish version (4) of the Parenting
Stress Index self-report inventory (5) and
modiﬁed to this scale with a four-factor
construction. An index describing “pa-
rental stress” was calculated from the
mean of the scores. Four additional fac-
tors (relationship with spouse, sense of
competence of parenthood, social life,
and privacy) were assessed (scale 1–7
from worst to best).
Statistical analyses
Scoreswerecomparedusingindependent
samples’ t test. The associations between
parental stress, time from notiﬁcation of
the autoantibody result, and duration of
the study were examined using linear re-
gression analysis. Association between
group and categorical variables in the ep-
idemiological data were tested with 
2
statistics. The effect of epidemiological
variables was analyzed with regression
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Windows release 11.0 software (SPSS,
Chicago, IL) was used.
RESULTS
Sociodemographic characteristics
The parent groups were closely similar.
Mostlivedincouples;however,morepar-
ents in the autoantibody-positive group
thanthecontrolgrouplivedalone(7.7vs.
4.2%, P  0.03). The proportion of
chronicallyilladultswashigherintheau-
toantibody-positive group than in the
control group (23.9 vs. 16.5%, P 
0.007); also, the unemployment rate
tended to be higher. Similar trends were
seen in the diabetic group.
Parenting stress
Stress indexes were similar in parents of
antibody-positive children and control
parents. Fathers experienced less stress
than mothers (Table 1), considered par-
enthood easier (P  0.008), and had
more time for private life than mothers
(P  0.0001; data not shown). Control
parents showed similar sex difference.
Transient autoantibody positivity or the
presence of multiple permanent autoanti-
bodies in the child did not alter parental
stress level. Of note, parental stress was
similar whether or not the child partici-
pated in the prevention trial. There was
nodifferencebetweenparentsoftrialpar-
ticipants and parents who chose not to
enroll an eligible child (Table 1).
Parents whose child had developed
diabetes showed higher stress than con-
trol subjects (Table 1). They also consid-
ered child care and parenthood more
difﬁcult (P  0.032; data not shown) and
regarded parents’ responsibilities more
demanding and social relations more dif-
ﬁcult. They had more marital problems
and more distant relation with their
spouse than the control subjects (P 
0.013). The answers of the mothers and
fathers were similar.
Parental stress decreased with duration
of the follow-up (r  0.142, P  0.01).
Single parents had higher stress than cou-
ples. Urban environment, unemployment,
and chronic illness in the family were asso-
ciated with higher stress. Parental stress in-
creased with maternal age (r  0.115,
P  0.039) but not with paternal age.
CONCLUSIONS— Parental stress
was not increased when the family
learned that their child had progressed to
autoantibody positivity, or during the
preventiontrial.Atenrollment,theimpli-
cation was that although the 2–8% ge-
neticriskwasgreaterthanthe0.7%inthe
background population, the odds were
still strongly against a particular child to
develop diabetes. Multiple autoantibod-
ies increased the risk to 50%. The pre-
ventiontrialpresentedachoiceoftakingan
action with potentially beneﬁcial conse-
quences, or leaving the child without this
option. The urge to do something to pre-
vent diabetes is strong (6), and parents may
see an intervention trial either as an oppor-
tunity to actively interfere in the course of
events, or a daily reminder of the risk.
Parentalanxietyisnotsigniﬁcantlyel-
evated in screening programs for type 1
diabetes risk and further dissipates over
time (7–10). We did not observe the tem-
porary increase in anxiety after notiﬁca-
tion of positive autoantibody results
reported in some other studies (11). In
agreement with the experiences in the Di-
abetes Prevention Trial–Type 1 (DPT-1)
Study (11,12), even the long-term ran-
domized prevention trial did not increase
parental stress. In the ethnically homoge-
neousandwell-educatedFinnishpopula-
tion, the problems involved are probably
smaller than in many other countries.
Mothers had higher stress than fa-
thers, regarded parenthood as more de-
manding, and needed more social
support. This may reﬂect traditional pa-
Table 1—Parental stress expressed as parental stress index, with lower scores indicating higher stress levels
Parental stress index
Parents of an autoantibody-positive child Parents of a child with diabetes
Mean SEM P Mean SEM P
Autoantibody-positive child 4.50 0.05 Child with diabetes 4.18 0.12 0.005
Control 4.52 0.03 Control 4.56 0.05
Mothers 4.64 0.07 0.005 Mothers 4.09 0.07
Fathers 4.38 0.06 Fathers 4.29 0.06
Transient autoantibodies 4.50 0.06
Multiple permanent 4.49 0.07
Participated in intervention 4.48 0.10 Participated in intervention 4.16
Eligible, did not participate 4.51 0.11 Eligible, did not participate 4.21
Living alone 3.95 0.18 0.001 Living alone 3.25 0.43 0.012
Living as couples 4.55 0.05 Living as couples 4.27 0.11
Chronic illness in family 4.26 0.11 0.001 Chronic illness in family 3.73 0.29 0.03
No chronic illness 4.58 0.05 No chronic illness 4.32 0.11
Unemployment 4.45 0.13 Unemployment 3.97 0.37
No unemployment 4.61 0.06 No unemployment 4.68 0.10
Urban environment 4.42 0.06 0.027 Urban environment 4.09 0.15
Rural environment 4.64 0.05 Rural environment 4.34 0.21
P values are given for statistically signiﬁcant differences.
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awareness. Unrelated life experiences like
single parenthood and chronic illness in
the family increased the stress and may
call for special attention.
Stress and early negative life events
may associate with increased risk of
chronic diseases, including type 1 diabe-
tes (13–15). The association between the
development of autoimmunity and po-
tentially stressful life circumstances (Ta-
ble 1) supports this theory.
In conclusion, in a large population-
based cohort of children at increased ge-
netic risk for type 1 diabetes, parental
stress was not increased by notiﬁcation of
autoantibody positivity or participation
in the double-blinded prevention trial.
Theburdenofriskawarenesscanbemin-
imized by proper study setup.
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